Supreme Court Backhands Key Federal Circuit Test

Law360, New York (January 10, 2007, 12:00 AM EST) -- On January 9, 2007, the Supreme Court issued its highly-anticipated decision in MedImmune, Inc. v. Genentech, Inc., No. 05-608 (Scalia, J.), holding that a patent licensee may bring a declaratory judgment action seeking a decision that the licensed patent is invalid or not infringed even if the licensee is continuing to pay royalties under the license. Obviously, this decision will have a significant impact on licensor/licensee relationships and on the settlement of patent disputes.

Lost in most of the discussion of MedImmune, however, is the Supreme...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.